• 1
    Pflanz, S., Timans, J. C., Cheung, J., Rosales, R., Kanzler, H., Gilbert, J., Hibbert, L. et al., IL-27, a heterodimeric cytokine composed of EBI3 and p28 protein, induces proliferation of naive CD4(+) T cells. Immunity 2002. 16: 779790.
  • 2
    Trinchieri, G., Pflanz, S. and Kastelein, R. A., The IL-12 family of heterodimeric cytokines: new players in the regulation of T cell responses. Immunity 2003. 19: 641644.
  • 3
    Pflanz, S., Hibbert, L., Mattson, J., Rosales, R., Vaisberg, E., Bazan, J. F., Phillips, J. H. et al., WSX-1 and glycoprotein 130 constitute a signal-transducing receptor for IL-27. J. Immunol. 2004. 172: 22252231.
  • 4
    Cocco, C., Morandi, F. and Airoldi, I., Interleukin-27 and interleukin-23 modulate human plasmacell functions. J. Leukoc. Biol. 2011. 5: 729734.
  • 5
    Chen, Q., Ghilardi, N., Wang, H., Baker, T., Xie, M. H., Gurney, A., Grewal, I. S. et al., Development of Th1-type immune responses requires the type I cytokine receptor TCCR. Nature 2000. 407: 916920.
  • 6
    Bonneville, M., O'Brien, R. L. and Born, W. K., Gammadelta T cell effector functions: a blend of innate programming and acquired plasticity. Nat. Rev. Immunol. 2011. 10: 467478.
  • 7
    De Rosa, S. C., Andrus, J. P., Perfetto, S. P., Mantovani, J. J., Herzenberg, L. A., Herzenberg, L. A. and Roederer, M., Ontogeny of gamma delta T cells in humans. J. Immunol. 2004. 172: 16371645.
  • 8
    Kunzmann, V., Bauer, E. and Wilhelm, M., Gamma/delta T-cell stimulation by pamidronate. N. Engl. J. Med. 1999. 340: 737738.
  • 9
    Tanaka, Y., Morita, C. T., Tanaka, Y., Nieves, E., Brenner, M. B. and Bloom, B. R., Natural and synthetic non-peptide antigens recognized by human gamma delta T cells. Nature 1995. 375: 155158.
  • 10
    Cocco, C., Di Carlo, E., Zupo, S., Canale, S., Zorzoli, A., Ribatti, D., Morandi, F. et al., Complementary IL-23 and IL-27 anti-tumor activities cause strong inhibition of human follicular and diffuse large B-cell lymphoma growth in vivo. Leukemia 2011. 23. doi:10.1038/leu.2011.363
  • 11
    Benzaid, I., Monkkonen, H., Stresing, V., Bonnelye, E., Green, J., Monkkonen, J., Touraine, J. L. et al., High phosphoantigen levels in bisphosphonate-treated human breast tumors promote Vgamma9Vdelta2 T-cell chemotaxis and cytotoxicity in vivo. Cancer Res. 2011. 71: 45624572.
  • 12
    Bonneville, M. and Scotet, E., Human Vgamma9Vdelta2 T cells: promising new leads for immunotherapy of infections and tumors. Curr. Opin. Immunol. 2006. 18: 539546.
  • 13
    Brandes, M., Willimann, K. and Moser, B., Professional antigen-presentation function by human gammadelta T cells. Science 2005. 309: 264268.
  • 14
    Castella, B., Riganti, C., Fiore, F., Pantaleoni, F., Canepari, M. E., Peola, S., Foglietta, M. et al., Immune modulation by zoledronic acid in human myeloma: an advantageous cross-talk between Vgamma9Vdelta2 T cells, alphabeta CD8+ T cells, regulatory T cells, and dendritic cells. J. Immunol. 2011. 187: 15781590.
  • 15
    Castella, B., Vitale, C., Coscia, M. and Massaia, M., Vgamma9Vdelta2 T cell-based immunotherapy in hematological malignancies: from bench to bedside. Cell Mol. Life Sci. 2011. 68: 24192432.
  • 16
    Conti, L., Casetti, R., Cardone, M., Varano, B., Martino, A., Belardelli, F., Poccia, F. et al., Reciprocal activating interaction between dendritic cells and pamidronate-stimulated gammadelta T cells: role of CD86 and inflammatory cytokines. J. Immunol. 2005. 174: 252260.
  • 17
    Dechanet, J., Merville, P., Lim, A., Retiere, C., Pitard, V., Lafarge, X., Michelson, S. et al., Implication of gammadelta T cells in the human immune response to cytomegalovirus. J. Clin Invest. 1999. 103: 14371449.
  • 18
    Eberl, M. and Moser, B., Monocytes and gammadelta T cells: close encounters in microbial infection. Trends Immunol. 2009. 30: 562568.
  • 19
    Girardi, M., Oppenheim, D. E., Steele, C. R., Lewis, J. M., Glusac, E., Filler, R., Hobby, P. et al., Regulation of cutaneous malignancy by gammadelta T cells. Science 2001. 294: 605609.
  • 20
    Gomes, A. Q., Martins, D. S. and Silva-Santos, B., Targeting gammadelta T lymphocytes for cancer immunotherapy: from novel mechanistic insight to clinical application. Cancer Res. 2010. 70: 1002410027.
  • 21
    Jameson, J. and Havran, W. L., Skin gammadelta T-cell functions in homeostasis and wound healing. Immunol. Rev. 2007. 215: 114122.
  • 22
    Tsuda, J., Li, W., Yamanishi, H., Yamamoto, H., Okuda, A., Kubo, S., Ma, Z. et al., Involvement of CD56brightCD11c +cells in IL-18-mediated expansion of human gammadelta T cells. J. Immunol. 2011. 186: 20032012.
  • 23
    Canale, S., Cocco, C., Frasson, C., Seganfreddo, E., Di Carlo, E., Ognio, E., Sorrentino, C. et al., Interleukin-27 inhibits pediatric B-acute lymphoblastic leukemia cell spreading in a preclinical model. Leukemia 2011. 25: 18151824.
  • 24
    Cocco, C., Giuliani, N., Di Carlo, E., Ognio, E., Storti, P., Abeltino, M., Sorrentino, C. et al., Interleukin-27 acts as multifunctional antitumor agent in multiple myeloma. Clin. Cancer Res. 2010. 16: 41884197.
  • 25
    Gomes, A. Q., Correia, D. V., Grosso, A. R., Lanca, T., Ferreira, C., Lacerda, J. F., Barata, J. T. et al., Identification of a panel of ten cell surface protein antigens associated with immunotargeting of leukemias and lymphomas by peripheral blood gammadelta T cells. Haematologica 2010. 95: 13971404.
  • 26
    Matsui, M., Kishida, T., Nakano, H., Yoshimoto, K., Shin-Ya, M., Shimada, T., Nakai, S. et al., Interleukin-27 activates natural killer cells and suppresses NK-resistant head and neck squamous cell carcinoma through inducing antibody-dependent cellular cytotoxicity. Cancer Res. 2009. 69: 25232530.
  • 27
    Morandi, F., Chiesa, S., Bocca, P., Millo, E., Salis, A., Solari, M., Pistoia, V. et al., Tumor mRNA-transfected dendritic cells stimulate the generation of CTL that recognize neuroblastoma-associated antigens and kill tumor cells: immunotherapeutic implications. Neoplasia 2006. 8: 833842.